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Background
The membrane-proximal external region (MPER) of
HIV-1 gp41 is highly conserved and is targeted by
broadly neutralizing antibodies (bnAbs). Thus, it is an
attractive target for AIDS vaccine development. Here, we
describe a mini-protein that can induce bnAbs in rabbits.
Methods
We generated a mini-protein that is structurally rigid, yet
efficiently recognized by 2F5, 4E10 and Z13e1. It contains
the C-terminal 54 a.a. of gp41 ectodomain (gp41-54Q),
which includes the HR2 and the MPER. A 6xHis tag at the
C-terminus was used to attach gp41-54Q to Zn-chitosan,
which served as an antigen carrier/adjuvant. Rabbits were
immunized subcutaneously, 4 times, using two different
schedules (wks 0, 4, 9 and 16 vs. 0, 8, 16 and 24). A total
of 9 animals were immunized with gp41-54Q in 3 inde-
pendent experiments. Antibody responses were evaluated
by ELISA and in neutralization assays using both TZM-bl
and A3R5.7 cells.
Results
Eight of nine rabbits mounted bnAbs (89%). Neutralizing
activity was observed against all but two of 44 viruses eval-
uated to date, including 27 Tier 2 viruses from clades A,
B, C, D, AE, and CRF02_AG. Although Nabs could be
detected after three immunizations, a fourth immunization
was necessary for maximum neutralizing activity. The
slower immunization regimen induced higher Nab titers,
suggesting that longer rest periods improve affinity
maturation. Neutralization inhibition analyses using var-
ious peptides identified one neutralizing epitope (N671,
W672, F673 and D674) that overlaps with those recog-
nized by Z13e1, 4E10 and 10E8 mAbs. Based on antibody
absorption assays, there might be other non-linear
epitopes. We are in the process of generating rabbit mAbs
for more detailed analyses.
Conclusion
We have successfully demonstrated that we can reproduci-
bly induce bnAbs in rabbits using a mini-protein contain-
ing gp41 MPER. These results suggest that gp41 can be a
promising vaccine immunogen.
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